New Ebola Vaccine Showing Promise in Monkeys

Late last week, the Los Angeles Times reported that researchers at the National Institutes of Health’s National Institute of Allergy and Infectious Diseases (NIAID) are working on a vaccine that has shown to protect macaques from infection from the Ebola virus within seven days.

Known as VSV-EBOV or rVSV-ZEBOV, the vaccine is the same one that was also reported by the LA Times to be effective in human trials in Guinea.  Andrea Marzi, coauthor of the study published in Science, told the newspaper that the next objective of the study was to observe whether the vaccine could work as a treatment for Ebola after exposure to the virus.

To learn more about the study, please read the report in Science and the LA Times’ coverage of the discovery.